68 related articles for article (PubMed ID: 9119899)
1. Intrastriatal neurotoxin injections reduce in vitro and in vivo binding of radiolabeled rotenoids to mitochondrial complex I.
Kilbourn MR; Charalambous A; Frey KA; Sherman P; Higgins DS; Greenamyre JT
J Cereb Blood Flow Metab; 1997 Mar; 17(3):265-72. PubMed ID: 9119899
[TBL] [Abstract][Full Text] [Related]
2. Quantitative study of mitochondrial complex I in platelets of parkinsonian patients.
Blandini F; Nappi G; Greenamyre JT
Mov Disord; 1998 Jan; 13(1):11-5. PubMed ID: 9452319
[TBL] [Abstract][Full Text] [Related]
3. [3H]dihydrorotenone binding to NADH: ubiquinone reductase (complex I) of the electron transport chain: an autoradiographic study.
Higgins DS; Greenamyre JT
J Neurosci; 1996 Jun; 16(12):3807-16. PubMed ID: 8656275
[TBL] [Abstract][Full Text] [Related]
4. Assay of [3H]dihydrorotenone binding to complex I in intact human platelets.
Blandini F; Greenamyre JT
Anal Biochem; 1995 Sep; 230(1):16-9. PubMed ID: 8585613
[TBL] [Abstract][Full Text] [Related]
5. Evidence that the blockade of mitochondrial respiration by the neurotoxin 1-methyl-4-phenylpyridinium (MPP+) involves binding at the same site as the respiratory inhibitor, rotenone.
Krueger MJ; Singer TP; Casida JE; Ramsay RR
Biochem Biophys Res Commun; 1990 May; 169(1):123-8. PubMed ID: 2350337
[TBL] [Abstract][Full Text] [Related]
6. Energetic dysfunction in quinolinic acid-lesioned rat striatum.
Bordelon YM; Chesselet MF; Nelson D; Welsh F; Erecińska M
J Neurochem; 1997 Oct; 69(4):1629-39. PubMed ID: 9326292
[TBL] [Abstract][Full Text] [Related]
7. Short- and long-term consequences of intracranial injections of the excitotoxin, quinolinic acid, as evidenced by GFA immunohistochemistry of astrocytes.
Björklund H; Olson L; Dahl D; Schwarcz R
Brain Res; 1986 Apr; 371(2):267-77. PubMed ID: 2938667
[TBL] [Abstract][Full Text] [Related]
8. Intrastriatal infusion of the Parkinsonian neurotoxin, MPP(+), induces damage of striatal cell nuclei in Sprague-Dawley rats.
Banerjee R; Sreetama S; Saravanan KS; Chandra G; Nath De S; Mohanakumar KP
J Chem Neuroanat; 2006 Dec; 32(2-4):90-100. PubMed ID: 16822645
[TBL] [Abstract][Full Text] [Related]
9. Rats with unilateral median forebrain bundle, but not striatal or nigral, lesions by the neurotoxins MPP+ or rotenone display differential sensitivity to amphetamine and apomorphine.
Sindhu KM; Banerjee R; Senthilkumar KS; Saravanan KS; Raju BC; Rao JM; Mohanakumar KP
Pharmacol Biochem Behav; 2006 Jun; 84(2):321-9. PubMed ID: 16820197
[TBL] [Abstract][Full Text] [Related]
10. Relative survival of striatal projection neurons and interneurons after intrastriatal injection of quinolinic acid in rats.
Figueredo-Cardenas G; Anderson KD; Chen Q; Veenman CL; Reiner A
Exp Neurol; 1994 Sep; 129(1):37-56. PubMed ID: 7925841
[TBL] [Abstract][Full Text] [Related]
11. Developmental regulation of BDNF and NT-3 expression by quinolinic acid in the striatum and its main connections.
Checa N; Canals JM; Alberch J
Exp Neurol; 2000 Sep; 165(1):118-24. PubMed ID: 10964490
[TBL] [Abstract][Full Text] [Related]
12. NMDA receptor overstimulation triggers a prolonged wave of immediate early gene expression: relationship to excitotoxicity.
Shan Y; Carlock LR; Walker PD
Exp Neurol; 1997 Apr; 144(2):406-15. PubMed ID: 9168840
[TBL] [Abstract][Full Text] [Related]
13. Age-dependent differences in survival of striatal somatostatin-NPY-NADPH-diaphorase-containing interneurons versus striatal projection neurons after intrastriatal injection of quinolinic acid in rats.
Figueredo-Cardenas G; Chen Q; Reiner A
Exp Neurol; 1997 Aug; 146(2):444-57. PubMed ID: 9270055
[TBL] [Abstract][Full Text] [Related]
14. Modulation of striatal quinolinate neurotoxicity by elevation of endogenous brain kynurenic acid.
Harris CA; Miranda AF; Tanguay JJ; Boegman RJ; Beninger RJ; Jhamandas K
Br J Pharmacol; 1998 May; 124(2):391-9. PubMed ID: 9641558
[TBL] [Abstract][Full Text] [Related]
15. Silibinin pretreatment attenuates biochemical and behavioral changes induced by intrastriatal MPP+ injection in rats.
Geed M; Garabadu D; Ahmad A; Krishnamurthy S
Pharmacol Biochem Behav; 2014 Feb; 117():92-103. PubMed ID: 24345573
[TBL] [Abstract][Full Text] [Related]
16. Methylphenylpyridium ion (MPP+) enhances glutamate-induced cytotoxicity against dopaminergic neurons in cultured rat mesencephalon.
Sawada H; Shimohama S; Tamura Y; Kawamura T; Akaike A; Kimura J
J Neurosci Res; 1996 Jan; 43(1):55-62. PubMed ID: 8838574
[TBL] [Abstract][Full Text] [Related]
17. 1-Methyl-4-phenylpyridinium produces excitotoxic lesions in rat striatum as a result of impairment of oxidative metabolism.
Storey E; Hyman BT; Jenkins B; Brouillet E; Miller JM; Rosen BR; Beal MF
J Neurochem; 1992 May; 58(5):1975-8. PubMed ID: 1560246
[TBL] [Abstract][Full Text] [Related]
18. Tyrosine-hydroxylase immunoreactive cells in the rat striatum following treatment with MPP+.
O'Byrne MB; Bolam JP; Hanley JJ; Tipton KF
Adv Exp Med Biol; 2000; 483():369-74. PubMed ID: 11787621
[TBL] [Abstract][Full Text] [Related]
19. Insecticides and acaricides which act at the rotenone-binding site of mitochondrial NADH:ubiquinone oxidoreductase; competitive displacement studies using a 3H-labelled rotenone analogue.
Jewess PJ
Biochem Soc Trans; 1994 Feb; 22(1):247-51. PubMed ID: 8206244
[No Abstract] [Full Text] [Related]
20. Acute intrastriatal administration of quinolinic acid affects the expression of the coat protein AP-2 and its interaction with membranes.
Borgonovo J; Seltzer A; Sosa MA
J Neural Transm (Vienna); 2009 Oct; 116(10):1201-8. PubMed ID: 19597933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
